CD34 and acute myeloid leukemia: In addition, human AML cells engraftment enabled the fractionation of LICs (CD34+ CD38−) into CD34+/CD71−/HLA-DR [217], CD34 Thy1 hematopoietic stem cells [218] and CD34/CD117 (or ckit) [219] subpopulations.